A meta-meta-analysis suggests carboplatin can replace cisplatin when particularly concerns for nephrotoxicity or ototoxicity predominate for most cancer sites other than urothelial carcinoma where clear meaningful benefits with cisplatin are clear. | Jimenez-Labaig, JAMA Netw Open 2026
